Identification of new therapeutic targets

We use of bioinformatics tools for the identification of genes involved in cancer. This is a complex task since it requires in vivo and in vitro validation of hypotheses generated by bioinformatics models using genomic and proteomic data.

The analysis of genomic data using regulatory networks also aims to identify new therapeutic targets. This target requires complex models in bioinformatics to translate hypotheses generated from genomic and proteomic data models into in vitro and in vivo validation experiments. We are in a very embryonic phase in this section but this is a long term important goal for its potential impact.